Real-World Treatment of ADC-Resistant HER2-Low Advanced Breast Cancer

NCT07587983 · clinicaltrials.gov ↗
COMPLETED
Status
220
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

The First Affiliated Hospital with Nanjing Medical University